560 related articles for article (PubMed ID: 36879504)
1. The role of immune activation and antigen persistence in acute and long COVID.
Opsteen S; Files JK; Fram T; Erdmann N
J Investig Med; 2023 Jun; 71(5):545-562. PubMed ID: 36879504
[TBL] [Abstract][Full Text] [Related]
2. Persistent CD8
LaVergne SM; Dutt TS; McFann K; Baxter BA; Webb TL; Berry K; Tipton M; Stromberg S; Sullivan BM; Dunn J; Henao-Tamayo M; Ryan EP
Front Immunol; 2023; 14():1303971. PubMed ID: 38327763
[TBL] [Abstract][Full Text] [Related]
3. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID.
Islam MS; Wang Z; Abdel-Mohsen M; Chen X; Montaner LJ
J Leukoc Biol; 2023 Mar; 113(3):236-254. PubMed ID: 36807444
[TBL] [Abstract][Full Text] [Related]
4. Viral persistence, reactivation, and mechanisms of long COVID.
Chen B; Julg B; Mohandas S; Bradfute SB;
Elife; 2023 May; 12():. PubMed ID: 37140960
[TBL] [Abstract][Full Text] [Related]
5. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
[TBL] [Abstract][Full Text] [Related]
6. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
Sherif ZA; Gomez CR; Connors TJ; Henrich TJ; Reeves WB;
Elife; 2023 Mar; 12():. PubMed ID: 36947108
[TBL] [Abstract][Full Text] [Related]
8. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).
Mohandas S; Jagannathan P; Henrich TJ; Sherif ZA; Bime C; Quinlan E; Portman MA; Gennaro M; Rehman J;
Elife; 2023 May; 12():. PubMed ID: 37233729
[TBL] [Abstract][Full Text] [Related]
9. Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection.
Newell KL; Waickman AT
Curr Opin Immunol; 2022 Aug; 77():102228. PubMed ID: 35724449
[TBL] [Abstract][Full Text] [Related]
10. Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19.
Williams GP; Yu ED; Shapiro K; Wang E; Freuchet A; Frazier A; Lindestam Arlehamn CS; Sette A; da Silva Antunes R
Hum Immunol; 2024 May; 85(3):110770. PubMed ID: 38433036
[TBL] [Abstract][Full Text] [Related]
11. Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.
Leung JM; Wu MJ; Kheradpour P; Chen C; Drake KA; Tong G; Ridaura VK; Zisser HC; Conrad WA; Hudson N; Allen J; Welberry C; Parsy-Kowalska C; Macdonald I; Tapson VF; Moy JN; deFilippi CR; Rosas IO; Basit M; Krishnan JA; Parthasarathy S; Prabhakar BS; Salvatore M; Kim CC
Front Immunol; 2024; 15():1348041. PubMed ID: 38318183
[TBL] [Abstract][Full Text] [Related]
12. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.
Proal AD; VanElzakker MB
Front Microbiol; 2021; 12():698169. PubMed ID: 34248921
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic factors behind long COVID: III. Persistence of SARS-CoV-2 and its components.
El-Baky NA; Amara AA; Uversky VN; Redwan EM
J Cell Biochem; 2024 Jan; 125(1):22-44. PubMed ID: 38098317
[TBL] [Abstract][Full Text] [Related]
14. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Peluso MJ; Lu S; Tang AF; Durstenfeld MS; Ho HE; Goldberg SA; Forman CA; Munter SE; Hoh R; Tai V; Chenna A; Yee BC; Winslow JW; Petropoulos CJ; Greenhouse B; Hunt PW; Hsue PY; Martin JN; Daniel Kelly J; Glidden DV; Deeks SG; Henrich TJ
J Infect Dis; 2021 Dec; 224(11):1839-1848. PubMed ID: 34677601
[TBL] [Abstract][Full Text] [Related]
15. Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection.
Minutolo A; Petrone V; Fanelli M; Maracchioni C; Giudice M; Teti E; Coppola L; Sorace C; Iannetta M; Tony Miele M; Bernardini S; Mastino A; Sinibaldi Vallebona P; Balestrieri E; Andreoni M; Sarmati L; Grelli S; Garaci E; Matteucci C
Int Immunopharmacol; 2023 May; 118():110055. PubMed ID: 36989892
[TBL] [Abstract][Full Text] [Related]
16. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2.
Yin K; Peluso MJ; Luo X; Thomas R; Shin MG; Neidleman J; Andrew A; Young KC; Ma T; Hoh R; Anglin K; Huang B; Argueta U; Lopez M; Valdivieso D; Asare K; Deveau TM; Munter SE; Ibrahim R; Ständker L; Lu S; Goldberg SA; Lee SA; Lynch KL; Kelly JD; Martin JN; Münch J; Deeks SG; Henrich TJ; Roan NR
Nat Immunol; 2024 Feb; 25(2):218-225. PubMed ID: 38212464
[TBL] [Abstract][Full Text] [Related]
17. Vaccination after developing long COVID: Impact on clinical presentation, viral persistence, and immune responses.
Nayyerabadi M; Fourcade L; Joshi SA; Chandrasekaran P; Chakravarti A; Massé C; Paul ML; Houle J; Boubekeur AM; DuSablon C; Boudreau V; Bovan D; Darbinian E; Coleman EA; Vinci S; Routy JP; Hétu PO; Poudrier J; Falcone EL
Int J Infect Dis; 2023 Nov; 136():136-145. PubMed ID: 37717649
[TBL] [Abstract][Full Text] [Related]
18. Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges.
Tsilingiris D; Vallianou NG; Karampela I; Christodoulatos GS; Papavasileiou G; Petropoulou D; Magkos F; Dalamaga M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445634
[TBL] [Abstract][Full Text] [Related]
19. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
Ryan FJ; Hope CM; Masavuli MG; Lynn MA; Mekonnen ZA; Yeow AEL; Garcia-Valtanen P; Al-Delfi Z; Gummow J; Ferguson C; O'Connor S; Reddi BAJ; Hissaria P; Shaw D; Kok-Lim C; Gleadle JM; Beard MR; Barry SC; Grubor-Bauk B; Lynn DJ
BMC Med; 2022 Jan; 20(1):26. PubMed ID: 35027067
[TBL] [Abstract][Full Text] [Related]
20. Multiple early factors anticipate post-acute COVID-19 sequelae.
Su Y; Yuan D; Chen DG; Ng RH; Wang K; Choi J; Li S; Hong S; Zhang R; Xie J; Kornilov SA; Scherler K; Pavlovitch-Bedzyk AJ; Dong S; Lausted C; Lee I; Fallen S; Dai CL; Baloni P; Smith B; Duvvuri VR; Anderson KG; Li J; Yang F; Duncombe CJ; McCulloch DJ; Rostomily C; Troisch P; Zhou J; Mackay S; DeGottardi Q; May DH; Taniguchi R; Gittelman RM; Klinger M; Snyder TM; Roper R; Wojciechowska G; Murray K; Edmark R; Evans S; Jones L; Zhou Y; Rowen L; Liu R; Chour W; Algren HA; Berrington WR; Wallick JA; Cochran RA; Micikas ME; ; Wrin T; Petropoulos CJ; Cole HR; Fischer TD; Wei W; Hoon DSB; Price ND; Subramanian N; Hill JA; Hadlock J; Magis AT; Ribas A; Lanier LL; Boyd SD; Bluestone JA; Chu H; Hood L; Gottardo R; Greenberg PD; Davis MM; Goldman JD; Heath JR
Cell; 2022 Mar; 185(5):881-895.e20. PubMed ID: 35216672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
